Bone drug lowers breast cancer risk 38% in high-risk women
Filed under Wellness by Conner Flynn on April 22nd, 2010
Related: Bone, Breast Cancer, Drug, high-risk, women
Related: Bone, Breast Cancer, Drug, high-risk, women
According to a new study, a common osteoporosis drug, raloxifene, reduces breast cancer risk by 38% in women at high risk for the disease, without causing the serious side effects of similar drugs.
That suggests more high-risk women should consider taking raloxifene, which is also known as Evista. Both raloxifene and tamoxifen, are approved to prevent breast cancer in women at high risk. Few women take them for prevention, however, because of concerns about side effects. And let’s face it, manufactured drugs do so much harm across the board, so you really can’t blame them. But if this study is accurate, women may change their minds.
Last Updated on April 22nd, 2010
Hey, before you go please subscribe to Healthy Reader or leave a comment.
| « Red Wine May Protect Brain From Stroke Damage | Arizona Man Loses 46 Years of Memories After Slip and Fall » |
